Eye School of Chengdu University of TCM, In eye Hospital of Chengdu University of TCM, Chengdu, China.
Beijing Ming Vision and Ophthalmology, Dongcheng District, Beijing, China.
PLoS One. 2021 Sep 23;16(9):e0257667. doi: 10.1371/journal.pone.0257667. eCollection 2021.
To quantitatively evaluate outcomes after small incision lenticule extraction (SMILE) combined with allogeneic intrastromal lenticule inlay for hyperopia with astigmatism.
It's a retrospective cohort study. Twenty-four eyes of 15 patients with more than 0.75 diopters (D) of astigmatism in hyperopic eyes were enrolled in this study. The hyperopic eye with astigmatism was first treated with SMILE to correct astigmatism; then a lenticule was extracted from a donor myopic eye and subsequently implanted into the hyperopic eye with astigmatism. Patients were examined preoperatively and 1 day, 1 week, 1,3 months and 1 year after surgery. The main outcome measures were the uncorrected and corrected distance visual acuity (UDVA and CDVA), uncorrected near visual acuity (UNVA), spherical equivalent (SE), corneal topography, anterior segment optical coherence topography (OCT) and ocular response analyzer (ORA) parameters: corneal hysteresis (CH) and corneal resistance factor (CRF). Repeated-measures analyses of variance (ANOVA) and post hoc tests were used to analyze data of different follow-up visits.
The mean preoperative cylinder was 1.95±1.04(D). The UDVA (from 0.37±0.23 to 0.09±0.09), UNVA (from 0.49±0.21 to 0.08±0.06), SE (from +7.42±3.12 to -0.75±0.79) and astigmatism (+1.95±1.04 to -0.65±0.63) postoperatively were obviously better than those before surgery. Five eyes (26.3%) gained one line of CDVA, and 3 eyes (15.8%) gained two lines of CDVA one year after surgery compared with preoperative levels. The average corneal curvature was changed from (43.19±4.37) D to (49.19±3.87) D one year after surgery. The anterior segment OCT images of corneas with lenticule inlays at each follow-up visit showed that the implanted lenticule was shaped like a crescent in the corneal stroma. The CH and CRF didn't change significantly after surgery (p = 0.189 and p = 0.107respectively).
SMILE combined with intrastromal lenticule inlay can be used to correct high hyperopia with astigmatism with good safety, efficacy and reproducibility.
定量评估小切口微透镜提取(SMILE)联合同种异体基质微透镜嵌体治疗远视伴散光的效果。
这是一项回顾性队列研究。共纳入 15 例(24 只眼)远视伴散光患者,每只眼散光大于 0.75 屈光度(D)。先对远视伴散光眼行 SMILE 手术矫正散光,再从供体近视眼中提取微透镜,然后将其植入远视伴散光眼中。患者术前及术后 1 天、1 周、1、3 个月和 1 年进行检查。主要观察指标为未矫正和矫正远视力(UDVA 和 CDVA)、未矫正近视力(UNVA)、等效球镜(SE)、角膜地形图、眼前节光学相干断层扫描(OCT)和眼反应分析仪(ORA)参数:角膜滞后(CH)和角膜阻力因子(CRF)。采用重复测量方差(ANOVA)分析和事后检验对不同随访时间点的数据进行分析。
平均术前柱镜为 1.95±1.04(D)。术后 UDVA(从 0.37±0.23 提高至 0.09±0.09)、UNVA(从 0.49±0.21 提高至 0.08±0.06)、SE(从+7.42±3.12 提高至-0.75±0.79)和散光(从 1.95±1.04 降低至-0.65±0.63)均明显优于术前。术后 5 只眼(26.3%)获得一行 CDVA,3 只眼(15.8%)获得两行 CDVA,与术前相比均有提高。术后 1 年平均角膜曲率从(43.19±4.37)D 变为(49.19±3.87)D。各随访时眼前节 OCT 图像显示,植入的微透镜在角膜基质中呈新月形。术后 CH 和 CRF 无明显变化(p = 0.189 和 p = 0.107)。
SMILE 联合基质微透镜嵌体可安全、有效、可重复地治疗高度远视伴散光。